During severe impact conditions, brain tissue experiences a rapid and complex deformation, which can be seen as a mixture of compression, tension and shear. Diffuse axonal injury (DAI) occurs in animals and humans when both the strains and strain rates exceed 10% and 10/s, respectively. Knowing the mechanical properties of brain tissue in shear at these strains and strain rates is thus of particular importance, as they can be used in finite element simulations to predict the occurrence of brain injuries under different impact conditions. However, very few studies in the literature provide this information. In this research, an experimental setup was developed to perform simple shear tests on porcine brain tissue at strain rates ≤120/s. The maximum measured shear stress at strain rates of 30, 60, 90 and 120/s was 1.15±0.25kPa, 1.34±0.19kPa, 2.19±0.225kPa and 2.52±0.27kPa, (mean±SD), respectively at the maximum amount of shear, K=1. Good agreement of experimental, theoretical (Ogden and Mooney-Rivlin models) and numerical shear stresses was achieved (p=0.7866-0.9935). Specimen thickness effects (2.0-10.0mm thick specimens) were also analyzed numerically and we found that there is no significant difference (p=0.9954) in the shear stress magnitudes, indicating a homogeneous deformation of the specimens during simple shear tests. Stress relaxation tests in simple shear were also conducted at different strain magnitudes (10-60% strain) with the average rise time of 14ms. This allowed us to estimate elastic and viscoelastic parameters (initial shear modulus, μ=4942.0Pa, and Prony parameters: g1=0.520, g2=0.3057, τ1=0.0264s, and τ2=0.011s) that can be used in FE software to analyze the non-linear viscoelastic behavior of brain tissue. This study provides new insight into the behavior in finite shear of brain tissue under dynamic impact conditions, which will assist in developing effective brain injury criteria and adopting efficient countermeasures against traumatic brain injury.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jmbbm.2013.07.017 | DOI Listing |
ACS Chem Biol
March 2025
Chemical Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, United States.
Tau aggregation plays a crucial role in the development of Alzheimer's disease (AD). Developing specific techniques that can isolate pathogenic tau from brain tissue is important for understanding tauopathies and advancing targeted therapies. Here, we develop photoaffinity small molecular probes and a novel method for tissue labeling and investigate their activity in interacting with tau in cells and AD patient brains.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
March 2025
Department of Neurology, School of Medicine, University of California at Davis, Sacramento, CA, USA.
Stroke is a multifaceted disease with genetic and environmental components like diet and lifestyle. The central nervous and immune systems display complex interactions, with the peripheral immune response participating in brain injury and repair mechanisms following stroke. The bidirectional communication between the injured brain and peripheral blood presents an opportunity to investigate the molecular changes in the latter.
View Article and Find Full Text PDFBackground: Acute ischemic stroke (AIS) requires timely thrombolysis to restore perfusion and minimize neurological damage. Recombinant human prourokinase (rhPro-UK) has emerged as a promising alternative to alteplase, with potential efficacy and safety benefits within the critical 4.5-h treatment window.
View Article and Find Full Text PDFToxicol Pathol
March 2025
Experimental Pathology Laboratories, Sterling, Virginia, USA.
The last session of the 2024 European Society of Toxicologic Pathology Congress was dedicated to recent neuro concepts, encompassing various topics including artificial intelligence (AI) applied to toxicologic pathology, new technologies for visualization and/or analysis of tissues, as well as specific case reports. Four presentations detailed the role of AI and computational pathology for toxicologic pathologists, usage of cryofluorescent tomography in neuropathology, blood-brain barrier organoids in early drug screening, and spatial transcriptomics in toxicologic pathology. In addition, there were two short presentations about a spontaneous brain lesion in Beagle dogs as well as central nervous system lesions related to adeno-associated virus vectors administration in various preclinical species.
View Article and Find Full Text PDFNeurol Res
March 2025
Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Background: Immunotherapy has promise for glioblastoma multiforme (GBM) treatment and disulfidptosis, a form of cell death involving disintegration of the actin cytoskeleton, is a potential target. The aim of the current study was to identify genes associated with disulfidptosis-related immune checkpoints in GBM and to analyze connections with malignancy.
Methods: Two expression matrices from The Cancer Genome Atlas-Genotype Tissue Expression (TCGA-GTEx) and Chinese Glioma Genome Atlas (CGGA) cyber public data were utilized to analyze differentially expressed genes (DEGs) in GBM and interaction networks for DEG-coded proteins constructed with protein-protein interaction network analysis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!